ClinicalTrials.Veeva

Menu

Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Completed

Conditions

Kidney Transplant

Study type

Observational

Funder types

Other

Identifiers

NCT01914354
859869783

Details and patient eligibility

About

This is an observational multi-center study to determine whether any single immune monitoring test or a combination of tests obtained in the first 6 months after renal transplantation correlates with acute rejection or graft loss in renal allograft recipients receiving commonly used immunosuppressive.

Enrollment

90 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • human kidney transplant recipients
  • ATG or basiliximab induction therapy

Exclusion criteria

  • induction therapy other than ATG or basiliximab

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems